← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2016Last known activity
Oct 31, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 4 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT05354778Lead sponsorN/AOct 31, 2022
- NCT05354778Overall official - principal investigatorN/AOct 31, 2022
- NCT05354778Reponsible party - principal investigatorN/AOct 31, 2022
- NCT02878837Reponsible party - principal investigatorPhase 4Jan 1, 2016
- NCT02878837Lead sponsorPhase 4Jan 1, 2016
Details
- Last known activity
- Oct 31, 2022